Library / Laws / 117th Congress / Senate Bills / S. 1634
S. 1634
To require the Food and Drug Administration to determine whether to permit the use of enriched enrollment randomized withdrawal methodology with respect to clinical trials.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2021-05-13 | 2.0K | ⠃⠗⠋ |